Lutetium-177 FL 091 - Full-Life Technologies
Alternative Names: Lu-177 FL-091Latest Information Update: 07 Nov 2024
Price :
$50 *
At a glance
- Originator Full-Life Technologies
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals; Small molecules
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Solid tumours
Most Recent Events
- 21 Jul 2024 FL 091 licensed to SK Biopharmaceuticals worldwide
- 10 Jun 2024 Lutetium-177 FL 091 - Full-Life Technologies is available for licensing as of 10 Jun 2024. https://www.full-life.com/partnering
- 10 Jun 2024 Preclinical trials in Solid tumours (Diagnosis) in China (Parenteral), before June 2024